Press release
What's Driving the Hiv Associated Nephropathy Market Trends? Analysis With Top Key Players GlaxoSmithKline Pharma GmbH, Gilead Sciences, Bristol-Myers Squibb, Abbott, Genentech
Human immunodeficiency virus (HIV) affects kidney function in patients. HIV-positive patients are at increased risk for a variety of renal disorders. HIV-associated nephropathy (HIVAN) is also one of the kidney disorder which affects HIV-positive patients. HIV-associated nephropathy (HIVAN) was first de-scribed in 1984 as the complication of acquired immune deficiency syndrome. HIV-associated nephropathy (HIVAN) starts with a large amount of protein in the urine and progresses rapidly to total kidney failure. Antiretroviral therapy preserved kidney function in patients with HIV. Treatment with An-tiretroviral drugs reduced the risk of the HIV-associated nephropathy. HIV Medicine Association and Infectious Diseases Society of America recommended the use of antiretroviral drugs (ART) for patients with HIV-associated nephropathy. In the various clinical studies, it’s suggested that corticosteroids and ACE inhibitors are also beneficial for the treatment of HIV-associated nephropathy.
Request Sample of This Report @ https://www.persistencemarketresearch.com/samples/27577
Some of the players operating in the global HIV-associated nephropathy market are GlaxoSmithKline Plc. (ViiV Healthcare Limited), Gilead Sciences, Inc., Bristol-Myers Squibb, Abbott Laboratories, Merck & Co., Inc., Tibotec, Genentech, Inc. F. Hoffmann-La Roche Ltd, Johnson & Johnson, eNovation Chemicals LLC, Active Biopharma Corp., and others.
The global market for HIV-associated nephropathy is expected to witness significant and continuous growth over the forecast period due to the rising number of HIV cases. In 2017, estimated 36.9 Mn people are suffered from HIV globally. Government and private organization take initiative to reduce the number of cases of HIV and support HIV treatment. These are the major factor expected to propel the growth of the HIV-associated nephropathy market. The program such as UNAIDS’ 90-90-90 is initiated for the prevention and treatment of HIV and associated disorders. Increasing HIV treatment access expected to favors the growth of the HIV-associated nephropathy market.
According to Avert Organization, in 2017, around 59% of all people living with HIV were accessing treatment as compared to past years. Moreover, in 2017, 21.7 Mn people living with HIV were receiving ART therapy which increased by 2.3 Mn from 2016. However, side effects associated with long-term use of ART expected to restrain the growth of the HIV-associated nephropathy market. Long-term use of ART therapy has been linked to various other diseases such as diabetic nephropathy and focal segmental glomerulosclerosis.
The global HIV-associated nephropathy market is segmented on basis of drug class, distribution chan-nel and region:
• Segmentation by Drug Class
o Antiretroviral Drugs
o Protease inhibitors
o Corticosteroids
o Angiotensin-converting enzyme (ACE) inhibitors
• Segmentation by Distribution Channel
o Hospital Pharmacies
o Retail Pharmacies
o Online Pharmacies
o
Request For Toc @ https://www.persistencemarketresearch.com/toc/27577
HIV-associated nephropathy market expected to represent a significant growth rate over the forecast period. Antiretroviral drugs expected to gain high share in HIV-associated nephropathy market over the forecast period. Moreover, funding for the treatment of HIV and associated diseases treatment have propelled the growth of the HIV-associated nephropathy market. The increasing number of HIV-associated nephropathy cases expected to favor the growth of the HIV-associated nephropathy market.
Regionally, the global HIV-associated nephropathy market is segmented into five key regions viz. North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. North America is expected to contribute significant revenue share in the global HIV-associated nephropathy market owing to high awareness regarding infectious diseases and increasing healthcare expenditure. Europe also shows the high growth rate in the HIV-associated nephropathy market due to the increasing government funding programs for treatment and increasing treatment-seeking population. HIV-associated nephropathy market in the Asia-Pacific region is expected to witness significant growth rate in the coming years due to increasing healthcare expenditure, government initiatives, increasing per capita income.
Middle East Africa also contributes high revenue share in HIV-associated nephropathy market as the highest prevalence of HIV in the world and increasing prevention, education and treatment programs for HIV. The vast majority of people living with HIV are live in low and middle-income countries. From total HIV infected patient, around 66% of people are living in Sub-Saharan Africa.
The report covers exhaustive analysis on:
• HIV-Associated Nephropathy Market Segments
• HIV-Associated Nephropathy Market Dynamics
• Historical Actual Market Size, 2013 - 2017
• HIV-Associated Nephropathy Market Size & Forecast 2018 to 2026
• HIV-Associated Nephropathy Market Current Trends/Issues/Challenges
• Competition & Companies involved
• HIV-Associated Nephropathy Market Drivers and Restraints
Regional Analysis:
• North America
• Latin America
• Europe
• Asia Pacific
• Middle East & Africa
Report Highlights:
• Shifting industry dynamics
• In-depth market segmentation
• Historical, current and projected industry size recent industry trends
• Key competition landscape
• Strategies of key players and product offerings
• Potential and niche segments/regions exhibiting promising growth
• A neutral perspective towards market performance
Full Report @ https://www.persistencemarketresearch.com/market-research/hiv-associated-nephropathy-market.asp
ABOUT US:
Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance. To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.
CONTACT:
Persistence Market Research
305 Broadway
7th Floor, New York City,
NY 10007, United States,
USA – Canada Toll Free: 800-961-0353
Email: sales@persistencemarketresearch.com
Web: http://www.persistencemarketresearch.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release What's Driving the Hiv Associated Nephropathy Market Trends? Analysis With Top Key Players GlaxoSmithKline Pharma GmbH, Gilead Sciences, Bristol-Myers Squibb, Abbott, Genentech here
News-ID: 1782508 • Views: …
More Releases from persistencemarketresearch.com
Innovation-Based Discernment To Drive The Foil Shavers Market
Personal appearance has taken paramount importance in the lives of consumers. Proper grooming and professional appearance have become important attributes to gain respect at the workplace. The way people carry themselves creates an impression on co-workers and the management. The pressure and interest of looking good is equally important to both, men and women. Variations offered by trimmers and shavers have taken up the onus to drive the foil shavers…
Alcoholic Hepatitis Therapeutic Market Rugged Expansion Foreseen by 2017 to 2025
Alcoholic hepatitis is a kind of liver disease usually affects people who are used to be heavy drinkers. It can cause short and long-term liver damage. Liver is a major organ of body functions to remove poisons such as alcohol from blood. It’s damaged by long time heavy drinking of alcohol. Usually occur in 30% of long- time alcohol drinkers.
Asymptomatic steatohepatitis is also as alcoholic hepatitis the term is…
Advanced Meniscal Fixation Devices Market Continuing to Show Billion Dollar Grow …
Meniscal fixation is minimally invasive surgical procedure is used to reconstruct torn meniscus. Meniscus functions include distribution and load transmission, joint stability, neuromuscular proprioception and joint nutrition. Meniscal tears are symptomatic and irreparable and meniscal fixation devices are used to remove unstable fragments. Meniscal repair is performed only during longitudinal tears (>10 mm), tears without deformity or secondary degeneration, and others. Meniscal fixation devices are used arthroscopic repair or…
Liniments Rubs Market segmentation by key players - Liniments & Rubs Market are …
Liniments are liquid dosage forms which are used relieve pain and stiffness during arthritis, sore muscular aches, and muscle strains. Liniments & rubs are well absorbed through the skin and have a high bioavailability. Liniment vehicles depend on the type of action (counterirritants, massage, and rubefacient) and solubility of desired compounds. They can be used as irritants, analgesics, anti-inflammatory, astringents, and fungicidal. Rubefacient liniments are used for vasodilation and hyperthermia…
More Releases for HIV
HIV-Associated Lipodystrophy Treatment Market - Increasing prevalence of HIV is …
HIV-associated lipodystrophy also known as lipodystrophy is a syndrome that occurs in HIV-infected patients. It is characterized by loss of subcutaneous fat from face, buttocks, arms and legs. Although the exact cause of HIV-associated lipodystrophy is not fully elucidated, some research evidence reported that it occurs in HIV-infected patients who are under antiretroviral medications. According to an article published in National Center for Biotechnology Information (NCBI) in 2014, prevalence of…
Global HIV Drugs Market | Global HIV Drugs Industry | Global HIV Drugs Market Re …
Human immunodeficiency Virus (HIV) could be a chronic and severe sickness which might be transferred from one person to a different through blood-to-blood and sexual contact. it's a deadly disease that attacks immune cells called CD-4 cells, creating body vulnerable to infections and alternative diseases. Over the years, the rising prevalence of HIV sickness worldwide has completely influenced the demand for HIV medicine. HIV medicine facilitate in preventing the multiplication…
HIV Therapeutics Market– South Africa's Aspen launches three-in-one HIV drug
Recent Developments
Aspen Pharma care, a South Africa’s drug maker has launched a triple combination of tablet for the treatment of HIV in the country where the HIV virus is the most prevalent. The company's new Emdolten drug is a once a day tablet which is in the form of dolutegravir, an antiretroviral medication that balances the drug’s resistance. The company has launched Aspen Stavudine which was its first generic ARV…
HIV Vaccine Market HIV Vaccine Clinical Pipeline Report 2022
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990
Report Table of Contents
Introduction to Human Immunodeficiency Virus (HIV) Vaccines
1.1 Overview
1.2 Antiquity of HIV Vaccine
Need for the Development of HIV Vaccine
Primer of HIV inside the Body
3.1 Inclusion of HIV Virus into the System
3.2 Interaction of HIV with Host
3.3 Eradication of HIV Virus
HIV Vaccine Development Process
4.1 Introduction
…
Global HIV Vaccine Market & HIV Vaccine Clinical Trial Outlook 2022
Worldwide, around the 35 Million of the people are currently infected with the HIV and about 30 Million of the people died because of the AIDS infection. There is no human example of clearing an HIV infection naturally. HIV virus makes copies of it very quickly, many types of HIV exist and new types of virus are continue to rise. Many scientists are still trying to understand the specific ways…
Hidden HIV Revealed: New Insights Into Latent HIV Infections
In spite of ever more effective therapies, HIV keeps managing to survive in the body. A comprehensive project conducted by the Austrian Science Fund FWF has clarified the molecular processes which contribute to this effect. In the process, approaches were discovered for possible therapies to combat the hidden reservoir formed by the virus.
Thanks to modern therapies, HIV infections have become controllable – but these treatments cannot provide a cure. Antiretroviral…
